ESMO-Congress-2020-1000x250

ESMO 2020, the world's premier congress in medical oncology will be taking place in Madrid from the 18 - 22 September 2020.

The congress will attract an international community of experts, across disciplines and all focused on finding the most effective cancer treatment solutions available today.

This is the ultimate goal of ESMO 2020 and we count on our Industry Partners active in oncology to help us again further our science and improve the lives of patients through continued education.

Fast Facts: ESMO Congress 2019

  • 29’622 participants, 137 countries
  • 8’426 sqm exhibition space, 188 exhibitors
  • 588 invited speakers
  • 212 sessions ESMO, 15 sessions EONS
  • 3’904 submitted abstracts

How can I participate in 2020?

At ESMO we are committed to providing our industry partners with a variety of solutions to facilitate your presence at our congress.

Contact the  ESMO Events Sponsorship Team for more details and we look forward to hearing from you!

Who has already signed up?

We gratefully acknowledge the valuable contribution of the following organisations in the ESMO 2020 Congress through their presence in the exhibition hall, organisation of sponsored sessions, or via sponsorship activities (as of March 2020):

Companies

  • Advanced Accelerator Applications, a Novartis company
  • Amgen (Europe) GmbH
  • Amoy Diagnostics Co., Ltd.
  • Apogenix AG
  • Aptitude Health
  • Astellas Pharma Europe Ltd.
  • AstraZeneca
  • Bayer
  • Beacon Medicare Limited
  • BeiGene
  • Biocartis
  • BMJ
  • BMS Pfizer Alliance
  • Boehringer Ingelheim International GmbH
  • Bristol-Myers Squibb
  • Calithera Biosciences
  • Caris Life Sciences
  • Cancers MDPI
  • Catalysis S.L.
  • Celltrion Healthcare Co., Ltd.
  • Clovis Oncology
  • COR2ED
  • Daiichi Sankyo
  • Deciphera Pharmaceuticals, LLC
  • Eisai Europe Ltd.
  • Eli Lilly and Company
  • EUSA Pharma Limited
  • Exact Sciences
  • Exelixis
  • F.Hoffmann-La Roche LTD.
  • Ferring International Center SA
  • Genmab
  • GSK
  • Guardant Health, Inc.
  • HalioDx
  • Helsinn Healthcare
  • Illumina
  • Incyte Biosciences International Sarl
  • Ipsen
  • ITM Isotopen Technologien Muenchen AG
  • JAMA Network
  • Janssen Pharmaceutica NV
  • Kaiku Health
  • Karger Publishers
  • Kite, a Gilead Company
  • LeCancer.fr
  • Life Technologies Ltd.
  • Med Learning Group
  • medac GmbH
  • Medscape Oncology
  • Menarini Silicon Biosystems
  • Merck
  • MSD
  • Mylan GmbH
  • National Comprehensive Cancer Network (NCCN)
  • NEJM Group
  • NeoGenomics
  • Novartis Oncology
  • Oncology Central
  • Pfizer Oncology
  • PharmaMar
  • Philips Molecular Pathway Diagnostics
  • Pierre Fabre
  • Precision for Medicine, Oncology and Rare Disease
  • Rakuten Medical, Inc.
  • Samsung Bioepis Co., Ltd.
  • Sanofi Genzyme
  • Seattle Genetics
  • Servier
  • Sotio a.s.
  • Springer Healthcare
  • Stemline Therapeutics
  • Syneos Health
  • Sysmex Inostics GmbH
  • Takeda Oncology
  • Taylor & Francis
  • Varian
  • VJOncology
  • WeHealth Digital Medicine
  • Wisepress Ltd.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings